Sjoerd Rodenhuis - Publications

Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: December 07, 2016

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.

Journal: PloS one

Published: November 12, 2016

PET/CT with 18F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 09, 2016

Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?

Journal: Cureus

Published: February 06, 2016

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.

Journal: Breast cancer research : BCR

Published: December 02, 2015

Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 01, 2015

The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure.

Journal: Breast cancer research and treatment

Published: May 03, 2015

Recurrent upper respiratory tract infections during and after rituximab therapy

Journal: Nederlands tijdschrift voor geneeskunde

Published: April 09, 2015

Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response.

Journal: Breast cancer research : BCR

Published: November 17, 2014

Breast cancer subtype specific classifiers of response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypes.

Journal: PloS one

Published: October 28, 2013

Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 08, 2013

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy.

Journal: Breast cancer research : BCR

Published: October 08, 2013